Article
Quantitative <i>in vivo</i> bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts
2020-05-16
Abstract excerpt
Despite extensive research, little progress has been made in glioblastoma therapy, owing in part to a lack of adequate preclinical in vivo models to study this disease. To mitigate this, primary patient-derived cell lines, which maintain their specific stem-like phenotypes, have replaced established glioblastoma cell lines. However, due to heterogenous tumour growth inherent in glioblastoma, the use of primary ce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dae47021-4c43-5008-9a93-10a94545b936
- DOI
- 10.1101/2020.05.15.098640
